Cognizant's Shared Investigator Platform Grows to More Than a Quarter Million Users Globally

Published on: 

Cognizant announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution that streamlines clinical trials, has surpassed 250,000 users across 100 countries worldwide. This digital platform facilitates research and collaboration by allowing clinical study documents and safety notifications to be exchanged across site and sponsor teams.

Read more about the platform here.